The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis

FGFR1 amplification is recognized as a novel therapy target for non-small-cell lung cancer (NSCLC), especially in squamous cell carcinoma (SCC). However, the association between FGFR1 amplification and the clinicopathological characteristics of NSCLC remains controversial. We performed a meta-analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Fa-Jun, Lu, Hong-Yang, Zheng, Qiu-Qing, Qin, Jing, Gao, Yun, Zhang, Yi-Ping, Hu, Xun, Mao, Wei-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708197/
https://www.ncbi.nlm.nih.gov/pubmed/26793001
http://dx.doi.org/10.2147/OTT.S91848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708197/
https://www.ncbi.nlm.nih.gov/pubmed/26793001
http://dx.doi.org/10.2147/OTT.S91848

Ejemplares similares